Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Arrow LionHeart LVAD Trial Progress Supports 13% Stock Gain In February

Mar 11 2002

Related Content

RTI Hoping FDA Review Can Lead To Regeneration In 2002

Feb 25 2002

Cytyc Gets Digene After Long Courtship, On Verge Of New Indication

Feb 25 2002

S&N Has One-Third Of Arthroscopy Market Following $310 Mil. Oratec Buy

Feb 18 2002

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window